Korro Bio, Inc.
KRRO· Nasdaq
KRROKorro Bio, Inc.
Filed Aug 12, 2020 · 10-Q · 43 days after period end · 0001564590-20-039488
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Revenue | $8.52M | — | — |
| Net Income | -$6.03M | -$6.85M | -$4.44M |
| EPS Diluted | -$0.19 | -$3.42 | -$3.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Korro Bio, Inc. · CIK 1703647 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 12, 2020 · 43 d after period end
